This study aims to evaluate the mid-term outcomes of mechanical thrombectomy for acute ischemic stroke in patients with active cancer.
Propensity-matched design using a cohort from the Lyon Stroke Center.
Inclusion of patients who underwent reperfusion treatments for stroke since 2013.
Compliance with ETIS standards, with a registry entry at ClinicalTrials.gov (NCT03776877).
Findings indicate favorable outcomes for mechanical thrombectomy in cancer patients, though specific metrics were not detailed in the abstract.
Resumen
cohort from the Lyon Stroke Center, enrolling all patients who underwent reperfusion treatments for stroke since 2013, in accordance with ETIS standards (ClinicalTrials.govNCT03776877).